Biocare Medical Revenue and Competitors

Pacheco, CA USA

Location

$85M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Biocare Medical's estimated annual revenue is currently $58.1M per year.(i)
  • Biocare Medical received $Undisclosed in venture funding in August 2017.
  • Biocare Medical's estimated revenue per employee is $193,750
  • Biocare Medical's total funding is $85M.

Employee Data

  • Biocare Medical has 300 Employees.(i)
  • Biocare Medical grew their employee count by 7% last year.

Biocare Medical's People

NameTitleEmail/Phone
1
VP, GPO and National AccountsReveal Email/Phone
2
VP, Marketing & E-commerceReveal Email/Phone
3
VP, Reagent Research and DevelopmentReveal Email/Phone
4
SVP, US CommercialReveal Email/Phone
5
Senior Director Quality Assurance and Regulatory AffairsReveal Email/Phone
6
Director PathologyReveal Email/Phone
7
CFO & Chief Strategy OfficerReveal Email/Phone
8
Director Electrical EngineeringReveal Email/Phone
9
Chief Commercial OfficerReveal Email/Phone
10
Director, Molecular Technology DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Biocare Medical?

Biocare Medical LLC is an innovator in automated immunohistochemistry (IHC) instrumentation, and the full range of reagents for IHC and in situ hybridization (ISH; RISH) testing. Biocare pioneered multiplex IHC detection which accelerates turnaround time, increases instrument productivity and reduces reagent consumption and cost by 50% or more. Multiplex IHC allows pathologists to visualize more than one marker on a tissue at a time, allowing higher confidence for critical differentiation. Biocare's intelliPATH FLX is the only completely open, continuous random access IHC instrument available. The company's customers come from clinical and research environments that do tissue based testing and include histology laboratories, pharmaceutical and biotechnology companies; CROs; and academic, government and military labs. Biocare Medical offers an expanding portfolio of products for the rapidly growing cancer and infectious disease diagnostic and research markets. Biocare medical is headquartered and has manufacturing facilities in Concord, Calif., and has a global distribution network. See biocare.net and slidestainer.com for more information. NOTE: Biocare Medical, the Biocare Medical logo, and intelliPATH are trademarks of Biocare Medical LLC.

keywords:Biotechnology,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals

$85M

Total Funding

300

Number of Employees

$58.1M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Biocare Medical News

2022-04-19 - Slide Stainer Market Size, Scope And Outlook | Agilent ...

Agilent Technologies Biocare Medical, Biogenex, Merck Group, Hardy Diagnostics, General Data Company Inc., F. Hoffmann-La Roche Ltd.,...

2022-04-19 - Immunohistochemistry (IHC) Market Size, Scope And Outlook ...

... Hoffmann-La Roche Ltd., Agilent Technologies Danaher, Bio SB Becton, Dickinson and Company, Merck KGaA, PHC Holdings Corporation, Biocare Medical, LLC.

2022-04-17 - Slippery Elm Products Market Size 2022-2029| Key Players ...

Biocare Medical; NOW Health Group; Dr. Willmar Schwabe; Herbs Hands Healing; Integria Healthcare; Health & Herbs; Nature's Garden; MedlinePlus Supplements...

2017-08-27 - Biocare Medical Receives Investment from Excellere Partners

Biocare Medical, a Pacheco, California-based provider of immunohistochemistry instrumentation, as well as a full range of reagents for IHC and molecular testing, received an investment from Excellere Partners. The amount of the deal was not disclosed. The investment will help the company enhan ...

Biocare Medical Funding

DateAmountRoundLead InvestorsReference
2017-08-28$UndisclosedUndisclosedExcellere PartnersArticle